RESUMEN
AIM: To assess compliance with Joint National Committee 7 (JNC 7) guidelines and evaluate target blood pressure (BP) goals among patients with hypertension. RESULTS: Basic laboratory workup was completed on 75% of patients, and 71% received smoking cessation counseling. Overall BP goal achievement was 45.6%; it was 27.6% and 21.1% among diabetes and chronic kidney disease (CKD) patients, respectively. An average of 2.6 antihypertensive medications were prescribed per patient, with beta-blockers being the most frequently used, followed by thiazide diuretics and angiotensin-converting enzyme inhibitors (ACEIS). ACEIS or angiotensin receptor blockers (ARBs) were not prescribed for 16% of diabetics, 26% of chronic renal failure patients, or 41% of those with history of stroke. Among heart failure patients, 24.1% were not on ACEI or ARBs, and 20.7% were not receiving beta-blockers. CONCLUSIONS: Certain aspects of JNC 7 are not well incorporated into clinical practice, especially among patients with coexisting diabetes and/or CKD.
Asunto(s)
Antihipertensivos/uso terapéutico , Adhesión a Directriz/estadística & datos numéricos , Hipertensión/tratamiento farmacológico , Guías de Práctica Clínica como Asunto , Consumo de Bebidas Alcohólicas , Presión Sanguínea , Comorbilidad , Femenino , Hospitales de Enseñanza , Humanos , Hipertensión/terapia , Masculino , Persona de Mediana Edad , Aptitud Física , Estudios Retrospectivos , Cese del Hábito de FumarRESUMEN
Several recent reports have described porphyria cutanea tarda (PCT) occurring in patients with HIV infection. Current evidence suggests that HIV infection may impair the hepatic cytochrome oxidase system, which could lead to an aberration in porphyrin metabolism and subsequently cause porphyria. We report a case of PCT in an HIV-infected patient who had multiple risk factors for this disorder.